Biotech, deals, Stem Cells

PerkinElmer Completes ViaCell Tender Offer

Rebecca Zacks 11/9/07

Waltham, MA-based PerkinElmer (NYSE: PKI) has successfully completed its tender offer for Cambridge’s ViaCell (NASDAQ: VIAC), the company announced today. The company purchased more than 90% of ViaCell’s outstanding shares in the transaction, which is part of a $300 million acquisition announced early in October. PerkinElmer expects to complete the merger “promptly.”